Search for: "Eli Lilly & Co."
Results 581 - 600
of 1,009
Sort by Relevance
|
Sort by Date
23 Feb 2011, 10:18 pm
Eli Lilly & Co., 598 F.3d 1336, 1354 (Fed. [read post]
23 Feb 2011, 10:58 am
Court of Appeals for the Federal Circuit in Eli Lilly & Co. v. [read post]
23 Feb 2011, 9:49 am
Eli Lilly & Co., 598 F.3d 1336, 1354 (Fed. [read post]
19 Feb 2011, 3:32 pm
Co. v. [read post]
18 Feb 2011, 4:11 pm
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
9 Feb 2011, 7:36 am
Patent numbers 5,859,006 and 6,140,329, were filed by Icos Corporation, which was acquired by Indiana-based Eli Lilly in 2007. [read post]
3 Feb 2011, 2:11 pm
Bristol-Myers Squibb Co., 121 F. [read post]
2 Feb 2011, 3:52 am
Meda Pharma GmbH & Co. [read post]
31 Jan 2011, 8:10 am
Eli Lilly, just to name a few. [read post]
31 Jan 2011, 8:10 am
Eli Lilly, just to name a few. [read post]
26 Jan 2011, 10:04 am
Eli Lilly & Co., 598 F.3d 1336, 1347 (Fed. [read post]
24 Jan 2011, 12:31 pm
On January 20, 2011, Eli Lilly and Company of Indianapolis, Indiana (“Lilly”) filed a complaint requesting that the ITC commence an investigation pursuant to Section 337. [read post]
20 Jan 2011, 4:50 pm
Cir. 2009); Liebel-Flarsheim Co. v. [read post]
11 Jan 2011, 1:06 pm
See Accomac Realty Co. v. [read post]
29 Dec 2010, 12:54 pm
Eli Lilly & Co., 620 F.3d 121 (2d Cir. 2010). [read post]
24 Nov 2010, 12:37 am
Use of pipeline system (IP tango) EU: Notes from EU Parliament meeting on innovation+access for medical technologies (KEI) Netherlands: District Court of The Hague declares Dutch part of Bayer’s European patent covering anti-TNF alpha human monoclonal antibodies invalid (Kluwer Patent Blog) Southeast Asia: Generic drug market picks up steam in Southeast Asia, finds Front & Sullivan (GenericsWeb) Spain: Commercial Court No 5 of Barcelona: obtaining price for generic medicament an act of… [read post]
17 Nov 2010, 9:20 am
Eli Lilly & Co. [read post]
10 Nov 2010, 1:11 am
Roche (Filewrapper) (Property, intangible) US: Senator Sanders letter to FDA: U.S. needs an ethical pathway for biological products (KEI) (FDA Law Blog) US: Daiichi Sankyo seeks review and correction of patent term adjustment calculation for patent relating to ‘nucleoside and oligonucleotide analogues’ (Patent Docs) US: CAFC in Abraxis v Navinta: remembering Stanford/Roche (IPBiz) Products Alimta (Pemetrexed) – US: Eli Lilly files patent infringement complaint… [read post]
9 Nov 2010, 8:18 am
In Eli Lilly and Co. v. [read post]
4 Nov 2010, 9:13 pm
Eli Lilly & Co., No. 2010-1105 (Fed. [read post]
